AU
UK
BIONOMICS LIMITED (ASX:BNO)
Company
Key Dates
Announcements
BNO Licensee, Ironwood submits IND Application for Anti-Anxiety DrugFri, 9 Nov 2012 11:45am
Deborah Rathjen, CEO
Bionomics presents at the ASX Small to Mid Caps conference in Hong KongTue, 30 Oct 2012 9:15am
Deborah Rathjen, Managing Director
Tue, 2 Oct 2012 11:30am
Deborah Rathjen, Managing Director
Mon, 17 Sep 2012 11:00am
Dr Deborah Rathjen, CEO & Managing Director
Wed, 13 Jun 2012 9:00am
Deborah Rathjen, Managing Director
Mon, 2 Apr 2012 1:00pm
Deborah Rathjen, CEO and Managing Director 
Mon, 20 Feb 2012 11:05am
Dr Deborah Rathjen, Managing Director 
Fri, 11 Nov 2011 9:45am
Dr Deborah Rathjen, Managing Director, CEO
Fri, 4 Nov 2011 11:25am
Deborah Rathjen, Managing Director & CEO
Thu, 6 Oct 2011 10:15am
Dr Deborah Rathjen, CEO 
Executives & Directors
Interim Results
Thu, 14 Feb 2013
Annual General Meeting
Wed, 14 Nov 2012
Full Year Results
Wed, 15 Aug 2012
Interim Results
Tue, 14 Feb 2012
Annual General Meeting
Wed, 9 Nov 2011
Interim Results
Fri, 11 Feb 2011
Annual General Meeting
Wed, 13 Oct 2010
Annual General Meeting
Wed, 4 Nov 2009 3:00pm
EGM
Fri, 9 Oct 2009 11:00am
Full Year Results
Fri, 28 Aug 2009
| CTX AND BIONOMICS' PROGRAM REACHES KEY MILESTONE | Thu, 16 May 2013 |
| Change of Director's Interest Notice | Tue, 7 May 2013 |
| Bionomics NOW May 2013 Newsletter | Mon, 6 May 2013 |
| Appendix 3B | Thu, 2 May 2013 |
| Appendix 4C - quarterly | Tue, 30 Apr 2013 |
| Update on BNC101 Presented at Leading US Antibody Conference | Mon, 29 Apr 2013 |
| Manufacture of BNC101 commences at Lonza | Tue, 23 Apr 2013 |
| Rights Issue - Despatch of Holding Statements | Tue, 16 Apr 2013 |
| Change of Director's Interest Notice | Mon, 15 Apr 2013 |
| Non-renounceable rights issue - Share allotment | Thu, 11 Apr 2013 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.
